指南与共识医学教育与科研方法

指南制定组织指导文件第9篇:合作方法

Guideline organizations' guidance documents paper 9: co-operative approaches.
指南 / 共识 · J Clin Epidemiol · 2025-11-19

该研究系统检索了133家指南制定组织的公开指导文件,其中73家(55%)描述了至少一种合作方法,包括合作制定(59家)和背书(41家)。合作制定中最常涉及的要素是传播计划(50%),背书方法中合作条件最常被提及,但许多重要要素仍缺失或覆盖不足。

要点

  • 133家指南制定组织中73家(55%)描述了合作方法。
  • 合作制定最常涉及传播计划(50%)、团队结构与治理(48%)。
  • 背书方法中合作条件最常被提及,但许多要素缺失。

核心结论

  • 合作制定中最常描述的要素是传播计划,背书中最常涉及合作条件,许多重要要素覆盖不足或未涉及。

研究设计与样本

  • 系统检索公开可得的指南制定组织指导文件,由两名作者评估资格并提取组织特征及合作政策数据。

主要发现

  • 133家指南制定组织中73家(55%)描述了至少一种合作方法,其中59家归类为合作制定,41家归类为背书。
  • 合作制定中最常涉及的要素包括传播计划(50%)、团队结构与治理(48%)、合作条件与决策权限(42%)、利益冲突政策(32%)。
  • 合作制定中最少涉及的要素包括分工(2%)、沟通计划(2%)和撰写(2%),资源共享、共享收益和方案开发计划等要素完全未涉及。
  • 背书方法的要素因背书方或被背书方视角而异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Collaboration allows participants to share and leverage their strengths, mitigating resource limitations and duplication of efforts. Guideline-producing organizations interested in collaboration have developed policies to engage in collaborative effort. Our objective was to describe co-operative approaches to practice guideline development used by guideline-producing organizations as described in their guidance documents. METHODS: We conducted a systematic search to identify publicly available guidance documents from guideline-producing organizations. Two authors assessed eligibility and abstracted data on the organizations' characteristics and their policies for co-operative approaches in guideline development. Regarding key concepts in guideline development, co-operative approaches refer to collaborative efforts among different guideline-producing organizations to ensure the production of comprehensive practice guidelines. Collaboration involves a co-operative and co-ordinated effort between guideline-producing organizations, wherein multiple entities contribute to and engage in guideline development. Endorsement refers to the formal approval of practice guidelines by external entities, indicating their agreement or validation of the proposed guidelines. We distinguished between two perspectives of endorsement: i) Endorser: Organization X endorses guidelines established by an external organization. ii) Endorsee: External organizations endorse guidelines established by Organization X. We prespecified a list of co-operation components based on findings from a systematic review on health research collaboration by academic entities. Additionally, we accommodated any emerging components identified from the data. Subsequently, we abstracted data related to these components. Our study excludes intraorganizational or interteam co-operation. We analyzed categorical variables using frequencies and percentages and summarized the findings in textual, graphical, and tabular formats. RESULTS: Of the 133 identified guideline-producing organizations that described their methods in a publicly available guidance document, 73 (55%) organizations described at least one co-operative approach (N = 59), classified as "collaboration" and (N = 41) as "endorsement." The most frequently addressed components for collaboration include dissemination plan (50%), team structure and governance (48%), conditions for co-operation and authority for decision to co-operate (42%), and conflict of interest policy (32%). The least addressed components include division of labor (2%), communication plan (2%), and writing (2%). Many components, such as sharing resources, shared benefits, and protocol development plan, were not addressed at all. Components of the endorsement approach varied depending on whether the perspective was an endorser or an endorsee organization. CONCLUSION: The most commonly described component for collaboration was dissemination plans. For endorsement, conditions for co-operation were most frequently addressed. Many important components were either insufficient or not covered.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Zeidan L, Abou Mansour M, Schünemann HJ, et al. Guideline organizations' guidance documents paper 9: co-operative approaches. J Clin Epidemiol. 2025. PMID: 41270895. doi:10.1016/j.jclinepi.2025.112066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。